Skip to main content
File #: 18-8450    Version: 1 Name: Zoetis Pharmaceuticals 2019
Type: Agenda Item Status: Consent Agenda
File created: 11/14/2018 In control: City Council
On agenda: 12/11/2018 Final action: 12/11/2018
Title: Change Order/Renewal with Zoetis US, a sole source provider for veterinarian pharmaceuticals to add $25,000 annually for additional allowances bringing the annual amount estimated amount to $40,000 and authorize the City Manager to execute the three remaining renewal options with aggregate price fluctuations up to $50,000 so long as sufficient funding is appropriated by the City Council to satisfy the City's obligation during the renewal terms
Attachments: 1. 18-8478 Expenditure Information Form.pdf

From

A. Bryce Davis, Purchasing Manager

 

Title

Change Order/Renewal with Zoetis US, a sole source provider for veterinarian pharmaceuticals to add $25,000 annually for additional allowances bringing the annual amount estimated amount to $40,000 and authorize the City Manager to execute the three remaining renewal options with aggregate price fluctuations up to $50,000 so long as sufficient funding is appropriated by the City Council to satisfy the City's obligation during the renewal terms

 

Presenter

Jim Cummings, Environmental Services Director

 

Recommended Action

Approve

 

Analysis

City Contract No. 17038 for Zoetis Pharmaceuticals, a sole source provider of Antisedan, Dexdomitor, Covenia, and Cerenia, was executed on March 6, 2017 to provide up to $9,000 in veterinarian pharmaceuticals to the Animal Services division.  This contract was for an initial term of one year with four additional one-year renewals available. In December of 2017 a change order was approved by Council increasing the contract value to $15,000 due to an underestimated annual usage.

 

Upon completion of the additional Prairie Paws veterinarian clinic, the City is more than doubling the number of animals requiring these medications thus City Staff recommends a change order to accommodate an increased usage of the drugs estimated to surpass the contract value in future terms.

 

Contract Term:                                          Value:                                          Proposed Value:

Term 1                                                               $9,000                                                               No Change

Term 2                                                               $15,000                                          No Change

Term 3                                                               $15,000                                          $40,000

Term 4                                                               $15,000                                          $40,000

Term 5                                                               $15,000                                          $40,000

Grand Total                                          $69,000                                          $144,000*                     *Increase of $75,000 in total.

 

Financial Consideration

Funding is provided in the FY 2018/2019 General Fund Operating Budget, Animal Services (301110-60235).  Funding for future fiscal years will be paid from that year’s approved budgets.